株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

関節鏡検査装置市場 - 成長、傾向、および予測

Arthroscopy Devices Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 871442
出版日 ページ情報 英文 116 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.31円で換算しております。
Back to Top
関節鏡検査装置市場 - 成長、傾向、および予測 Arthroscopy Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年02月01日 ページ情報: 英文 116 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

世界の関節鏡検査装置市場は2019年から2024年の間に6%のCAGRで成長する見通しです。市場成長要因には、スポーツ傷害の発生率の増加、老年人口の増加、および関節鏡インプラントの技術的進歩などがあげられます。

当レポートでは関節鏡検査装置市場について調査しており、市場概況や成長要因・阻害要因、用途・製品・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報をまとめています。

目次

第1章 イントロダクション

  • 研究成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • スポーツ傷害の発生率の増加
    • 老年人口の増加
    • 鏡視下関節インプラントの技術的進歩
  • 市場阻害要因
    • 熟練した外科医の不足
    • 厳しい規制要件
    • 高価な関節鏡検査装置
  • ポーターファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界の競争

第5章 市場セグメント

  • 用途
    • 膝関節鏡検査
    • 股関節鏡検査
    • 脊椎関節鏡検査
    • 肩と肘の関節鏡検査
    • その他
  • 製品別
    • 関節鏡
    • 関節鏡インプラント
    • 液体管理システム
    • 無線周波数(RF)システム
    • 可視化システム
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Arthrex Inc.
    • Conmed Corporation
    • Johnson & Johnson
    • Karl Storz GmbH & Co. KG
    • Medtronic Plc.
    • Richard Wolf GmbH
    • Smith & Nephew Plc
    • Stryker Corporation

第7章 市場機会および今後の動向

目次
Product Code: 57113

The arthroscopy devices market is expected to witness a CAGR of 6%, during the forecast period. Certain factors that are driving the market growth include increasing incidences of sports injuries, rising geriatric population, and technological advancements in arthroscopic implants.

Fractures, strains, sprains, and dislocations are the most common sports injuries. The usual self-treatment recommended for these injuries includes rest, ice, compression, and elevation (RICE). For serious injuries that need more attention, an arthroscopy could be recommended, depending on the situation. Injuries can occur in various places and can be of various types. Some of the common injuries include shoulder, hip, knee, elbow, wrist, or ankle injuries; cartilage tears or ligament injuries; inflammation of the lining of the joints; removal of loose fragments of bone or cartilage that become lodged in a joint; and osteoarthritis caused by cartilage loss in a joint. Some of these may require arthroscopic surgery, as it is helpful in their diagnosis and treatment. According to the US Centers for Disease Control (CDC), participation in organized sports is increasing. Each year, approximately 30 million children and adolescents participate in youth sports in the United States. Out of them, athletes from high schools account for an estimated 2 million injuries, 0.5 million doctor visits, and 30,000 hospitalizations, every year. Moreover, more than 3.5 million kids under the age of 14 years receive medical treatment for sports injuries, every year. Children between the age of 5-14 years account for nearly 40% of all sports injuries treated in hospitals. In the United States, injuries associated with participation in sports and recreational activities accounted for 21% of all traumatic brain injuries among children, in 2017. The above-mentioned statistics exhibit an increased number of injuries that require arthroscopy procedures, which is expected to have a positive impact on the market studied.

However, the average standard cost of an outpatient treatment using arthroscopic surgery for complicated tears can cost about USD 7,400-9,000, or even more, depending on the age of the patient, the severity and exact location of the injury, the related injuries, and on the hospital where the procedure is performed. The Agency for Healthcare Research and Quality sponsors a series of medical databases. One such database, namely, Healthcare Cost and Utilization, shows that an outpatient arthroscopic surgery typically costs USD 8,970. For insured patients, out-of-pocket costs typically consist of a specialist co-pay, i.e., mostly a hospital copay of USD 100 or more, and coinsurance of 10-50% for the procedure, which could reach the yearly out-of-pocket maximum. According to the Kaiser Family Foundation, the average hospital copay is USD 132 for outpatient surgery, and USD 232 for inpatient surgery, and the average coinsurance rate is 17-18%. This shows that the average cost of arthroscopic procedures is very high, which could lead to people not opting for the procedure. Hence, high cost proves to be a potential restraint for the market.

Key Market Trends

Knee Arthroscopy is Expected to Hold Significant Market Share in the Application Segment

Degenerative knee disease is a globally occurring phenomenon among the elderly, which is gaining prevalence due to an increase in the global geriatric population. According to WHO, approximately 25% of the people older than 50 years experience knee pain from degenerative knee disease. The pain is impairing in nature, and often, a knee replacement procedure is the final and only resort to alleviate the pain. Arthroscopic knee surgery for degenerative knee disease is the most common orthopedic procedure in the United States and other developed countries. According to the CDC estimates, healthcare expenditure in the United States, toward arthroscopic procedures for degenerative knee disease, amounted to more than 3 billion USD, in 2015. The demand for knee arthroscopy is increasing globally, due to the increasing prevalence of sports injuries, particularly those acquired in contact sports.

North America Dominates the Market and the Trend is Expected to Continue during the Forecast Period

In the past two decades, there has been a drastic increase in the number of arthroscopies performed in North America. Knee arthroscopy and hip arthroscopy witnessed the highest growth. According to estimates derived from the Humana Claims database, the number of hip arthroscopies witnessed a very high growth rate, from 2007 to 2014. The highest incidence was registered by patients belonging to the age group of 35-44 years. The number of hip arthroscopies performed in North America is continuing to increase, along with an increase in the complexity and diversity of procedures. The diversity of procedures is indicative of the advancements in arthroscopy products and the highly active research ecosystem for arthroscopic applications. The increase in arthroscopy procedures in the region is driven by the increasing prevalence of chronic diseases and orthopedic ailments, especially among the aging population of the region. Additionally, there has been a drastic increase in the prevalence of sports injuries in North America. This is directly correlated to the increased number of arthroscopy procedures that are being performed in the region.

Competitive Landscape

The arthroscopy devices market is highly competitive and consists of a number of major players. Companies, like Arthrex Inc., Conmed Corporation, Johnson & Johnson (DePuy Synthes), Karl Storz GmbH & Co. KG, Medtronic PLC, Richard Wolf GmbH, Smith & Nephew PLC, and Stryker Corporation, among others, hold the substantial share in the market studied.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Sports Injuries
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Technological Advancements in Arthroscopic Implants
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Surgeons
    • 4.3.2 Stringent Regulatory Requirements
    • 4.3.3 High Cost of Arthroscopy Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Application
    • 5.1.1 Knee Arthroscopy
    • 5.1.2 Hip Arthroscopy
    • 5.1.3 Spine Arthroscopy
    • 5.1.4 Shoulder and Elbow Arthroscopy
    • 5.1.5 Other Arthroscopy Applications
  • 5.2 Product
    • 5.2.1 Arthroscope
    • 5.2.2 Arthroscopic Implant
    • 5.2.3 Fluid Management System
    • 5.2.4 Radiofrequency (RF) System
    • 5.2.5 Visualization System
    • 5.2.6 Other Products
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arthrex Inc.
    • 6.1.2 Conmed Corporation
    • 6.1.3 Johnson & Johnson
    • 6.1.4 Karl Storz GmbH & Co. KG
    • 6.1.5 Medtronic PLC
    • 6.1.6 Richard Wolf GmbH
    • 6.1.7 Smith & Nephew PLC
    • 6.1.8 Stryker Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top